Guidelines for Canadian drinking water quality boron: International considerations

The World Health Organization (WHO), U.S. EPA, Australia's National Health and Medical Research Council and the European Commission have developed guidelines or advisory values for boron in drinking water (Table 6). WHO (2011), Australia (NHMRC and NRMCC, 2011) and the European Commission (2020) have set guidelines for boron in drinking water of 2.4, 4 and 1.5 to 2.4 mg/L, respectively. The U.S. EPA does not have a maximum contaminant level (MCL) for boron in drinking water but has established a non-enforceable lifetime health advisory of 5 mg/L (U.S. EPA, 2008). Health advisories serve as informal technical guidance for unregulated drinking water contaminants in the United States. All organizations' values used decreased rat body weights as the critical effect. The differences in the values are attributable to differences in uncertainty factors, allocation factors, body weights and use of BMD modelling versus the NOAEL approach.

Table 6. International drinking water values for boron
Agency Year Value (mg/L) Basis (critical effect, POD and UF)
Regulatory values

WHOTable 6 Footnote 1

2011

2.4

Critical effect: decreased body weight in rat developmental studies (Heindel et al., 1992, 1994; Price et al 1996), BMD modelling from Allen et al (1996); BMD05 = 10.3 mg/kg bw per day

TDI = 0.17 mg/kg bw per day

UF = 60 (interspecies = 10; intraspecies = 6)

AustraliaTable 6 Footnote 2

2011

4

Critical effect (based on WHO (2004)): decreased body weight in rat developmental study (Price et al., 1996); NOAEL = 9.6 mg/kg bw per day

Adjusted TDI = 0.13 mg/kg bw per day (derived by subtracting background dietary and consumer product boron intake (0.03 mg kg bw per day) from a TDI of 0.16 mg kg bw per day)

UF = 60 (interspecies = 10; intraspecies = 6)

European CommissionTable 6 Footnote 3

2020

1.5 to 2.4

Information not available

Non-regulatory values

U.S. EPATable 6 Footnote 4

2008

5 (lifetime health advisory)

Critical effect: decreased body weight in rat developmental studies (Heindel et al., 1992, 1994; Price et al 1996), BMD modelling from Allen et al (1996); BMD05 = 10.3 mg/kg bw per day

RfD = 0.2 mg/kg bw per day

UF = 66 (interspecies = 10.5; intraspecies = 6.3)

BMD – benchmark dose; BMD05 – benchmark dose corresponding to a 5% increase in adverse effect over background rates; bw – body weight; NOAEL – no adverse effect level; POD – point of departure; RfD – reference dose; TDI – tolerable daily intake; UF – uncertainty factor; U.S. EPA – United States Environmental Protection Agency; WHO – World Health Organization

Table 6 Footnote 1

WHO (2009)

Table 6 Return to footnote 1 referrer

Table 6 Footnote 2

NHMRC and NRMCC (2011)

Table 6 Return to footnote 2 referrer

Table 6 Footnote 3

European Commission (2020)

Table 6 Return to footnote 3 referrer

Table 6 Footnote 4

U.S. EPA (2008)

Table 6 Return to footnote 4 referrer

Page details

Date modified: